Connect Biopharma Holdings Limited (CNTB)
NASDAQ: CNTB · Real-Time Price · USD
1.030
+0.030 (3.00%)
At close: Jun 20, 2025, 4:00 PM
1.040
+0.010 (0.97%)
After-hours: Jun 20, 2025, 5:46 PM EDT
CNTB Employees
Connect Biopharma Holdings had 62 employees as of December 31, 2024. The number of employees decreased by 19 or -23.46% compared to the previous year.
Employees
62
Change (1Y)
-19
Growth (1Y)
-23.46%
Revenue / Employee
$419,887
Profits / Employee
-$277,532
Market Cap
57.23M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 62 | -19 | -23.46% |
Dec 31, 2023 | 81 | -19 | -19.00% |
Dec 31, 2022 | 100 | -8 | -7.41% |
Jan 1, 2022 | 108 | 46 | 74.19% |
Dec 31, 2020 | 62 | - | - |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
AbbVie | 55,000 |
CNTB News
- 7 days ago - Connect Biopharma Presents Data Supporting Rademikibart at the European Academy of Allergy and Clinical Immunology (EAACI) 2025 Annual Congress - GlobeNewsWire
- 17 days ago - Connect Biopharma Announces Two Oral Presentations at the European Academy of Allergy and Clinical Immunology (EAACI) 2025 Annual Congress - GlobeNewsWire
- 23 days ago - Connect Biopharma to Present at Two Upcoming Investor Conferences in June - GlobeNewsWire
- 4 weeks ago - Connect Biopharma Presents Data Supporting Development of Rademikibart at the American Thoracic Society (ATS) 2025 International Conference - GlobeNewsWire
- 5 weeks ago - Connect Biopharma Reports First Quarter 2025 Financial Results and Provides Business Update - GlobeNewsWire
- 5 weeks ago - Connect Biopharma Initiates Phase 2 Seabreeze STAT COPD Study Evaluating Rademikibart for the Treatment of Acute Exacerbations in COPD - GlobeNewsWire
- 5 weeks ago - Connect Biopharma Initiates Phase 2 Seabreeze STAT Asthma Study Evaluating Rademikibart for the Treatment of Acute Exacerbations in Asthma - GlobeNewsWire
- 2 months ago - Connect Biopharma Announces Multiple Presentations at the American Thoracic Society (ATS) 2025 International Conference - GlobeNewsWire